Your browser doesn't support javascript.
loading
Real-world data on efficacy and safety of azacitidine therapy in chronic myelomonocytic leukemia in China: results from a multicenter, retrospective study.
Xu, Yu; Guo, Rong; Miao, Miao; Zhang, Guangsen; Lan, Jianping; Jin, Jie.
Afiliación
  • Xu Y; Department of Hematology, First Affiliated Hospital，Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • Guo R; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
  • Miao M; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
  • Zhang G; Departement of Hematology, The Second Xiangya Hospital of Central South University, Changsha, 430011, China.
  • Lan J; Department of Hematology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.
  • Jin J; Department of Hematology, First Affiliated Hospital，Zhejiang University School of Medicine, Hangzhou, 310003, China. jiej0503@zju.edu.cn.
Invest New Drugs ; 40(5): 1117-1124, 2022 10.
Article en En | MEDLINE | ID: mdl-35834039
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mielomonocítica Crónica Tipo de estudio: Observational_studies Límite: Humans / Middle aged Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mielomonocítica Crónica Tipo de estudio: Observational_studies Límite: Humans / Middle aged Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: China